These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 690834)

  • 21. Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers.
    Meseguer G; Buri P; Plazonnet B; Rozier A; Gurny R
    J Ocul Pharmacol Ther; 1996; 12(4):481-8. PubMed ID: 8951684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of pilocarpine delivery across isolated rabbit cornea by noncross-linked high viscosity polymer gel.
    Krohn DL; Breitfeller JM
    Invest Ophthalmol; 1976 Apr; 15(4):324-7. PubMed ID: 944172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vehicle effects on ophthalmic bioavailability: the influence of different polymers on the activity of pilocarpine in rabbit and man.
    Saettone MF; Giannaccini B; Teneggi A; Savigni P; Tellini N
    J Pharm Pharmacol; 1982 Jul; 34(7):464-6. PubMed ID: 6126549
    [No Abstract]   [Full Text] [Related]  

  • 24. Miotic effect and irritation potential of pilocarpine prodrug incorporated into a submicron emulsion vehicle.
    Sznitowska M; Zurowska-Pryczkowska K; Janicki S; Järvinen T
    Int J Pharm; 1999 Jul; 184(1):115-20. PubMed ID: 10425357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular absorption and irritation of pilocarpine prodrug is modified with buffer, polymer, and cyclodextrin in the eyedrop.
    Suhonen P; Järvinen T; Lehmussaari K; Reunamäki T; Urtti A
    Pharm Res; 1995 Apr; 12(4):529-33. PubMed ID: 7596987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of topical administration of 2.0% pilocarpine on intraocular pressure and pupil size in cats.
    Wilkie DA; Latimer CA
    Am J Vet Res; 1991 Mar; 52(3):441-4. PubMed ID: 2035919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pluronic F-127 gels as a vehicle for topical formulations of indomethacin and rheological behaviour of these formulations.
    Shawesh A; Kallioinen S; Hellén L; Antikainen O; Yliruusi J
    Pharmazie; 2002 Mar; 57(3):186-90. PubMed ID: 11933848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An increased effect of pilocarpine on the pupil by application of the drug in oil.
    Smith SA; Smith SE; Lazare R
    Br J Ophthalmol; 1978 May; 62(5):314-7. PubMed ID: 656357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of outflow facility and accommodative and miotic responses to pilocarpine in rhesus monkeys by muscarinic receptor subtype antagonists.
    Gabelt BT; Kaufman PL
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1133-9. PubMed ID: 1469625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of different ophthalmic vehicles on the activity of tropicamide in man.
    Saettone MF; Giannaccini B; Savigni P; Wirth A
    J Pharm Pharmacol; 1980 Jul; 32(7):519-21. PubMed ID: 6105197
    [No Abstract]   [Full Text] [Related]  

  • 31. Pluronic F127-based ocular delivery system containing biodegradable polyisobutylcyanoacrylate nanocapsules of pilocarpine.
    Desai SD; Blanchard J
    Drug Deliv; 2000; 7(4):201-7. PubMed ID: 11195426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of methylcellulose and carboxymethylcellulose on the biological availability of eye drops containing pilocarpine hydrochloride].
    Nerlo H; Wieluńska Z
    Ann Univ Mariae Curie Sklodowska Med; 1981; 36():67-71. PubMed ID: 7052782
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacodynamic effects of pilocarpine eye drop enhanced by decreasing its volume of instillation.
    Lal A; Kataria V; Rajpal A; Khanna N
    Indian J Physiol Pharmacol; 1995 Jul; 39(3):267-70. PubMed ID: 8550123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scintigraphic studies on the corneal residence of a New Ophthalmic Delivery System (NODS): rate of clearance of a soluble marker in relation to duration of pharmacological action of pilocarpine.
    Greaves JL; Wilson CG; Birmingham AT; Richardson MC; Bentley PH
    Br J Clin Pharmacol; 1992 Jun; 33(6):603-9. PubMed ID: 1389932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles.
    Kao HJ; Lin HR; Lo YL; Yu SP
    J Pharm Pharmacol; 2006 Feb; 58(2):179-86. PubMed ID: 16451745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solid-state ophthalmic dosage systems in effecting prolonged release of pilocarpine in the cul-de-sac.
    Loucas SP; Haddad HM
    J Pharm Sci; 1972 Jun; 61(6):985-6. PubMed ID: 5046133
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of urea on the activity of certain ophthalmic drugs in man.
    El-Nimr AE; Salama HA; Khalil RM; Kassem MA
    Pharmazie; 1983 Nov; 38(11):728-30. PubMed ID: 6689446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of topical dihydroergocristine on intraocular pressure, aqueous humor dynamics and pupil diameter in conscious rabbits. A comparative study with timolol and pilocarpine.
    Santafé Oroz J; Segarra Domenech J; Garrido García M; Pablo Martínez V
    Methods Find Exp Clin Pharmacol; 1991 May; 13(4):231-8. PubMed ID: 1908543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of different concentrations and of vehicle on pilocarpine miosis (author's transl)].
    Borgmann H; Wurster W
    Klin Monbl Augenheilkd; 1973 Jul; 163(1):44-50. PubMed ID: 4750512
    [No Abstract]   [Full Text] [Related]  

  • 40. A gelatin-g-poly(N-isopropylacrylamide) biodegradable in situ gelling delivery system for the intracameral administration of pilocarpine.
    Lai JY; Hsieh AC
    Biomaterials; 2012 Mar; 33(7):2372-87. PubMed ID: 22182746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.